Company news

Mesoblast Limited news in 2023

Mesoblast Limited's news releases, calls and decks from 2023, newest first.

View company

Information For Retail Shareholders

December 7, 2023

Mesoblast Completes Institutional Allocation

December 4, 2023

Entitlement Offer and Placement Investor Presentation

December 4, 2023

MSB Launches Entitlement Offer and Placement

December 4, 2023

Update on BLA for Graft Versus Host Disease

August 4, 2023

MSB Reports Q3 Financial Results and Operational Highlights

May 25, 2023

Third Quarter Financial Results on Form 6-K

May 25, 2023

Reinstatement to Official Quotation

April 26, 2023

Mesoblast Completes Private Placement

April 26, 2023

Voluntary Suspension

April 23, 2023

FDA Accepts Mesoblasts BLA Resubmission for Remestemcel-L

March 7, 2023

DREAM HF Trial Published in JACC

February 27, 2023

Half Yearly Report and Accounts

February 27, 2023

Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD

January 31, 2023

Calls in 2023

Decks in 2023